UK's MHRA advises on rules for medicine ads on web sites
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published advice for consumer web sites about the rules governing the advertising of medicines. The MHRA says that it wants to help companies to work within the parameters of the Medicines Advertising Regulations.
The guidance covers all web sites registered in the UK, or aimed at British consumers, which provide services that may lead to the prescription and or the supply of a prescription-only medicine (POM). It does not, however, apply to communications directed at health care professionals. Examples include diagnosis and therapeutic services for erectile dysfunction or treatment for lines and wrinkles.
The MHRA's top five advice tips are:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze